Results of trial of venetoclax with bendamustine/rituximab or bendamustine/obinutuzumab in CLL
The power of venetoclax
Empowering CLL patients: Do physicians need more communication skills training?
The use of the process of apoptosis for cancer treatments
Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.